![](https://investorshub.advfn.com/uicon/735854.png?cb=1621011866)
Thursday, April 30, 2020 11:21:55 AM
3/3
“Keith Berman, CEO of DECN commented, "We have the technology perfected which will take months off of the development schedule.”
The language is clear: there IS a development schedule, which is shortened by the availability of work completed previously. They do not have to re-invent the wheel to get started on the COVID test. Berman does not say, nor does he imply here, that the COVID test is at this point "perfected."
3/4
“What makes the testing for the Coronavirus possible, and the GenUltimate TBG special, is the company's Impedance measurement technology.”
This is made clear in the next citation below.
3/11
“Keith Berman, CEO of DECN commented, "Because we perfected the Impedance technology in 2019 for our GenUltimate TBG glucose test strip and meter, we have shaved months off of the development time for the GenViro! device.”
I'm not sure how much clearer the logic could be. If you take any one PR as a stand alone, you clearly failed to read the first PR, which should have been a clue: "Today, in a breakthrough discussed for the first time, DECN announces in this first of three releases, expected in the next 10 days, the introduction of our new screening methodology for the Coronavirs (Covid 19)."
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM